Related Experiment Video
Updated: Jun 17, 2025
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent
Limei Liu1, Miao Yang1, Ziyang Chen2
1Department of Endocrinology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Abstract:
The application of multidisciplinary techniques in the management of endocrine-related cancers is crucial for harnessing the advantages of multiple disciplines and their coordinated efforts in eliminating tumors. Due to the malignant characteristics of cancer cells, they possess the capacity to develop resistance to traditional treatments such as chemotherapy and radiotherapy. Nevertheless, despite diligent endeavors to enhance the prediction of outcomes, the overall survival rate for individuals afflicted with endocrine-related malignancy remains quite miserable. Hence, it is imperative to investigate innovative therapy strategies. The latest advancements in therapeutic tactics have offered novel approaches for the therapy of various endocrine tumors. This paper examines the advancements in nano-drug delivery techniques and the utilization of nanomaterials for precise cancer cures through targeted therapy. This review provides a thorough analysis of the potential of combined drug delivery strategies in the treatment of thyroid cancer, adrenal gland tumors, and pancreatic cancer. The objective of this study is to gain a deeper understanding of current therapeutic approaches, stimulate the development of new drug DDS, and improve the effectiveness of treatment for patients with these diseases. The intracellular uptake of pharmaceuticals into cancer cells can be significantly improved through the implantation of synthetic or natural substances into nanoparticles, resulting in a substantial reduction in the development of endocrine malignancies.
Insights
Innovative nanomedicine offers new hope for endocrine cancers, improving drug delivery and reducing tumor growth. This approach targets thyroid, adrenal, and pancreatic cancers, aiming to overcome treatment resistance and enhance patient survival rates.
Area of Science:
- Oncology
- Nanotechnology
- Drug Delivery Systems
Background:
- Endocrine-related cancers exhibit resistance to traditional therapies like chemotherapy and radiotherapy.
- Current treatment outcomes and survival rates for endocrine malignancies remain suboptimal.
- There is a critical need for innovative therapeutic strategies to improve cancer management.
Purpose of the Study:
- To review advancements in nano-drug delivery systems and nanomaterials for targeted cancer therapy.
- To analyze the potential of combined drug delivery strategies for thyroid, adrenal, and pancreatic cancers.
- To stimulate the development of novel drug delivery systems (DDS) and enhance treatment efficacy.
Main Methods:
- Review of current literature on nanotechnology applications in endocrine cancer treatment.
- Analysis of nano-drug delivery techniques and nanomaterial utilization for targeted therapy.
- Examination of combined drug delivery strategies for specific endocrine tumors.
Main Results:
- Nanoparticle-based drug delivery significantly enhances intracellular uptake of pharmaceuticals into cancer cells.
- Targeted delivery using nanomaterials shows potential for precise cancer cures.
- Implantation of substances into nanoparticles can substantially reduce endocrine malignancy development.
Conclusions:
- Nanomedicine presents a promising frontier for overcoming treatment resistance in endocrine cancers.
- Targeted nano-drug delivery systems offer improved therapeutic efficacy and reduced side effects.
- Further research into novel DDS is essential for improving patient survival and treatment outcomes.
More Related Videos
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
